Mr Hamza A Lodhi, MD | |
7601 Southcrest Parkway, Southaven, MS 38671 | |
(662) 772-2488 | |
(662) 772-3102 |
Full Name | Mr Hamza A Lodhi |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 7601 Southcrest Parkway, Southaven, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346479235 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mr Hamza A Lodhi, MD 445 Charles H Dimmock Pkwy Ste 100, Colonial Heights, VA 23834-2990 Ph: (804) 520-1764 | Mr Hamza A Lodhi, MD 7601 Southcrest Parkway, Southaven, MS 38671 Ph: (662) 772-2488 |
News Archive
When it comes to healthcare, Americans are not getting a lot of value for their money. The United States spends 17.6% of its gross domestic product, nearly twice the average of the nations in the Organization for Economic Cooperation and Development. But life expectancy in the United States in 2010, at 78.7 years, is below the OECD average of 79.8 years. The U.S. infant mortality rate is higher than in most developed countries -; it is higher than the rates in Greece, Hungary and Slovakia.
According to a new large-scale study, rising air pollution can be associated with not just physical problems such as heart and lung diseases but also mental health problems such as depression, schizophrenia and bipolar disorder.
Telomeres, the repetitive sequences of DNA at the ends of linear chromosomes, have an important function: They protect vulnerable chromosome ends from molecular attack.
EndoGastric Solutions (EGS) today announced the closing of a $21.5 Million Series E financing. The funding will be used to support an expanding commercial presence for the company's market-leading Natural Orifice Surgery (NOS) platform, which includes the EsophyX and StomaphyX surgical devices.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that the China Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase 2 global clinical trial in ovarian clear cell carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.
› Verified 1 days ago
Chaitanya Are, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-2980 Fax: 662-772-2960 |